JP2024506435A5 - - Google Patents

Info

Publication number
JP2024506435A5
JP2024506435A5 JP2023525002A JP2023525002A JP2024506435A5 JP 2024506435 A5 JP2024506435 A5 JP 2024506435A5 JP 2023525002 A JP2023525002 A JP 2023525002A JP 2023525002 A JP2023525002 A JP 2023525002A JP 2024506435 A5 JP2024506435 A5 JP 2024506435A5
Authority
JP
Japan
Application number
JP2023525002A
Other languages
Japanese (ja)
Other versions
JP2024506435A (ja
JPWO2022093373A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/047824 external-priority patent/WO2022093373A1/en
Publication of JP2024506435A publication Critical patent/JP2024506435A/ja
Publication of JP2024506435A5 publication Critical patent/JP2024506435A5/ja
Publication of JPWO2022093373A5 publication Critical patent/JPWO2022093373A5/ja
Pending legal-status Critical Current

Links

JP2023525002A 2020-10-26 2021-08-26 化合物、組成物、および骨折を処置するための使用方法 Pending JP2024506435A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063105669P 2020-10-26 2020-10-26
US63/105,669 2020-10-26
US202163193748P 2021-05-27 2021-05-27
US63/193,748 2021-05-27
PCT/US2021/047824 WO2022093373A1 (en) 2020-10-26 2021-08-26 Compounds,compositions and methods of use to treat bone fractures

Publications (3)

Publication Number Publication Date
JP2024506435A JP2024506435A (ja) 2024-02-14
JP2024506435A5 true JP2024506435A5 (https=) 2024-09-03
JPWO2022093373A5 JPWO2022093373A5 (https=) 2024-09-03

Family

ID=81383093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023525002A Pending JP2024506435A (ja) 2020-10-26 2021-08-26 化合物、組成物、および骨折を処置するための使用方法

Country Status (7)

Country Link
US (1) US20230399374A1 (https=)
EP (1) EP4232074A4 (https=)
JP (1) JP2024506435A (https=)
AU (1) AU2021370296A1 (https=)
CA (1) CA3194776A1 (https=)
MX (1) MX2023004796A (https=)
WO (1) WO2022093373A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018102616A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
WO2019232285A1 (en) 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
WO2022093374A1 (en) * 2020-10-26 2022-05-05 Purdue Research Foundation Compounds,compositions and methods of use to treat spinal fusions
AU2022205801A1 (en) * 2021-01-05 2023-07-13 Radius Health, Inc. Treatment of long bone fractures with abaloparatide
CN117373681B (zh) * 2023-10-30 2024-04-26 中国航天科工集团七三一医院 一种基于血糖调节系统作用的骨折愈合仿真方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2883707A1 (en) * 2012-08-28 2014-03-06 The Governors Of The University Of Alberta Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof
WO2018102616A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
WO2019232285A1 (en) * 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
WO2022093374A1 (en) * 2020-10-26 2022-05-05 Purdue Research Foundation Compounds,compositions and methods of use to treat spinal fusions

Similar Documents

Publication Publication Date Title
JP2024506435A5 (https=)
JP2023547889A5 (https=)
CN306071916S (https=)
CN305774963S (https=)
CN305536280S (https=)
CN305536095S (https=)
CN305535214S (https=)
CN305534307S (https=)
CN305534104S (https=)
CN305533737S (https=)
CN305532924S (https=)
CN305532852S (https=)
CN305532139S (https=)
CN305531357S (https=)
CN305530395S (https=)
CN305656539S (https=)
CN305529703S (https=)
CN305655432S (https=)
CN305527499S (https=)
CN305527352S (https=)
CN305526991S (https=)
CN305655057S (https=)
CN305641958S (https=)
CN305610646S (https=)
CN306134821S (https=)